Literature DB >> 23818329

Longitudinal weight gain in women identified with polycystic ovary syndrome: results of an observational study in young women.

Helena J Teede1, Anju E Joham, Eldho Paul, Lisa J Moran, Deborah Loxton, Damien Jolley, Catherine Lombard.   

Abstract

OBJECTIVE: Polycystic ovary syndrome (PCOS) affects 6-18% of women. The natural history of weight gain in women with PCOS has not been well described. Here we aimed to examine longitudinal weight gain in women with and without PCOS and to assess the association between obesity and PCOS prevalence. DESIGN AND METHODS: The observational study was set in the general community. Participants were women randomly selected from the national health insurance scheme (Medicare) database. Mailed survey data were collected by the Australian Longitudinal Study on Women's Health. Data from respondents to survey 4, aged 28-33 years (2006, n = 9,145) were analyzed. The main outcome measures were PCOS prevalence and body mass index (BMI).
RESULTS: Self-reported PCOS prevalence was 5.8% (95% CI: 5.3%-6.4%). Women reporting PCOS had higher weight, mean BMI [2.5 kg/m(2) (95% CI: 1.9-3.1)], and greater 10-year weight gain [2.6 kg (95% CI: 1.2-4.0)]. BMI was the strongest correlate of PCOS status with every BMI increment increasing the risk of reporting PCOS by 9.2% (95% CI: 6%-12%).
CONCLUSIONS: This community based observational study with longitudinal reporting of weight shows that weight, BMI, and 10-year weight gain were higher in PCOS. We report the novel finding that obesity and greater weight gain are significantly associated with PCOS status. Considering the prevalence, major health and economic burden of PCOS, the increasing weight gain in young women, and established benefits of weight loss, these results have major public health implications.
Copyright © 2012 The Obesity Society.

Entities:  

Mesh:

Year:  2013        PMID: 23818329     DOI: 10.1002/oby.20213

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  68 in total

1.  Anogenital distance in newborn daughters of women with polycystic ovary syndrome indicates fetal testosterone exposure.

Authors:  E S Barrett; K M Hoeger; S Sathyanarayana; D H Abbott; J B Redmon; R H N Nguyen; S H Swan
Journal:  J Dev Orig Health Dis       Date:  2018-01-09       Impact factor: 2.401

2.  Metabolic Evidence of Diminished Lipid Oxidation in Women With Polycystic Ovary Syndrome.

Authors:  Leah D Whigham; Daniel E Butz; Hesam Dashti; Marco Tonelli; Luann K Johnson; Mark E Cook; Warren P Porter; Hamid R Eghbalnia; John L Markley; Steven R Lindheim; Dale A Schoeller; David H Abbott; Fariba M Assadi-Porter
Journal:  Curr Metabolomics       Date:  2014

3.  Habitual physical activity is associated with improved anthropometric and androgenic profile in PCOS: a cross-sectional study.

Authors:  F M Mario; S K Graff; P M Spritzer
Journal:  J Endocrinol Invest       Date:  2016-10-22       Impact factor: 4.256

Review 4.  Hyperandrogenic origins of polycystic ovary syndrome - implications for pathophysiology and therapy.

Authors:  David H Abbott; Daniel A Dumesic; Jon E Levine
Journal:  Expert Rev Endocrinol Metab       Date:  2019-02-15

5.  Irregular menstrual cycles in a young woman.

Authors:  Jacqueline A Boyle; Helena J Teede
Journal:  CMAJ       Date:  2014-05-05       Impact factor: 8.262

6.  PCOS: Refining diagnostic features in PCOS to optimize health outcomes.

Authors:  Jacqueline A Boyle; Helena J Teede
Journal:  Nat Rev Endocrinol       Date:  2016-09-16       Impact factor: 43.330

7.  A Commentary on the New Evidence-Based Lifestyle Recommendations for Patients with Polycystic Ovary Syndrome and Potential Barriers to Their Implementation in the United States.

Authors:  Brittany Y Jarrett; Annie W Lin; Marla E Lujan
Journal:  J Acad Nutr Diet       Date:  2018-12-12       Impact factor: 4.910

8.  Hyperandrogenism Accompanies Increased Intra-Abdominal Fat Storage in Normal Weight Polycystic Ovary Syndrome Women.

Authors:  Daniel A Dumesic; Alin L Akopians; Vanessa K Madrigal; Emmanuel Ramirez; Daniel J Margolis; Manoj K Sarma; Albert M Thomas; Tristan R Grogan; Rasha Haykal; Tery A Schooler; Bette L Okeya; David H Abbott; Gregorio D Chazenbalk
Journal:  J Clin Endocrinol Metab       Date:  2016-08-29       Impact factor: 5.958

9.  Avoiding OHSS: Controlled Ovarian Low-Dose Stimulation in Women with PCOS.

Authors:  D Fischer; C Reisenbüchler; S Rösner; J Haussmann; P Wimberger; M Goeckenjan
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-06       Impact factor: 2.915

Review 10.  Metformin in women with PCOS, cons.

Authors:  Marie L Misso; Helena J Teede
Journal:  Endocrine       Date:  2014-09-02       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.